News

Article

Hovione and H&T Presspart Extend Partnership for Dry Powder Inhalation Formulation Delivery

Author(s):

Presspart will still be responsible for the manufacturing of the Sunriser device.

Hovione and H&T Presspart have partnered to advance the development of Presspart’s Sunriser Capsule-based Dry Powder Inhaler platform. The companies plan to work together to develop the Sunriser Dry Powder Inhaler, which is flexible enough to address the challenges of carrier-based and spray-dried engineered formulations, according to the press release.

A part of the development agreement finds Hovione being an exclusive partner with Presspart to use the Sunriser device in engineered formulations for dry powder inhalation. Additionally, Presspart will still be responsible for the manufacturing of the Sunriser device.

"New inhalable therapies are often requiring delivery of higher doses of cohesive and sensitive powders. Our priority is to ensure maximum efficiency in delivering these drugs to the right locations in the lung,” said Jean-Luc Herbeaux, PhD, CEO of Hovione, in a press release. “We are thrilled to expand our current partnership with Presspart and combine our expertise in the fields of engineered particles and inhalers for the benefit of our customers and patients.”

Source: Hovione

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content